🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this trial is to determine preliminary activity of the combinati...
Status
Recruiting
Location
Sydney Children's Hospital
Start Date
2020-05-26
Trial ID
NCT03838042
Treatments Being Tested
Primary objective: To evaluate the efficacy of two different dosing schedul...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00185302
This phase I/II trial is studying the side effects and best dose of azaciti...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00387465
Treatments Being Tested
This study will assess the immunomodulatory activity of entinostat in patie...
Status
Terminated
Location
Indiana University Health Hospital
Start Date
2017-06-29
Trial ID
NCT03024437
Treatments Being Tested
The primary objective of the open-label, dose-escalation study is to invest...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02623751
Treatments Being Tested
The objectives of this study are to explore different dosing levels and sch...
Status
Completed
Location
The START Center for Cancer Care
Start Date
2016-09-20
Trial ID
NCT02909452
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of entinos...
Status
Completed
Location
HOPE (Hematology Oncology Physicians & Extenders)
Start Date
2008-01-08
Trial ID
NCT00602030
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerance of entino...
Status
Completed
Location
Cancer Hospital Chinese Academy Medical Sciences
Start Date
2016-08-29
Trial ID
NCT02833155
Treatments Being Tested
To determine the safety and tolerability of Entinostat in combination with ...
Status
Terminated
Location
George Washington University - Medical Faculty Associates
Start Date
2019-05-01
Trial ID
NCT03829930
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of entinos...
Status
Terminated
Location
Johns Hopkins University
Start Date
2010-10
Trial ID
NCT01383447